Crossmark Global Holdings, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$21.87 - $28.24 $11,438 - $14,769	-523 Reduced 6.26%	7,828 $204,000
Q1 2024 May 13, 2024	BUY	$27.21 - $39.48 $30,094 - $43,664	1,106 Added 15.27%	8,351 $239,000
Q4 2023 Feb 13, 2024	SELL	$21.2 - $31.03 $12,126 - $17,749	-572 Reduced 7.32%	7,245 $221,000
Q3 2023 Nov 08, 2023	SELL	$26.2 - $36.08 $51,352 - $70,716	-1,960 Reduced 20.05%	7,817 $200,000
Q2 2023 Jul 31, 2023	SELL	$25.16 - $41.38 $9,435 - $15,517	-375 Reduced 3.69%	9,777 $343,000
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $8,264 - $13,439	-349 Reduced 3.32%	10,152 $258,000
Q4 2022 Jan 19, 2023	SELL	$28.0 - $40.56 $8,596 - $12,451	-307 Reduced 2.84%	10,501 $426,000
Q3 2022 Nov 01, 2022	SELL	$29.63 - $48.31 $4,563 - $7,439	-154 Reduced 1.4%	10,808 $357,000
Q2 2022 Jul 29, 2022	SELL	$27.79 - $50.61 $11,949 - $21,762	-430 Reduced 3.77%	10,962 $386,000
Q1 2022 May 11, 2022	BUY	$39.62 - $69.97 $12,678 - $22,390	320 Added 2.89%	11,392 $524,000
Q4 2021 Jan 10, 2022	BUY	$58.09 - $82.51 $40,663 - $57,757	700 Added 6.75%	11,072 $734,000
Q3 2021 Oct 21, 2021	BUY	$58.38 - $84.96 $605,517 - $881,205	10,372 New	10,372 $648,000
Q3 2021 Oct 13, 2021	SELL	$58.38 - $84.96 $616,492 - $897,177	-10,560 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$62.15 - $90.32 $15,537 - $22,580	-250 Reduced 2.31%	10,560 $875,000
Q1 2021 Apr 15, 2021	SELL	$61.35 - $90.47 $7,362 - $10,856	-120 Reduced 1.1%	10,810 $717,000
Q4 2020 Jan 14, 2021	SELL	$43.82 - $85.37 $73,617 - $143,421	-1,680 Reduced 13.32%	10,930 $839,000
Q3 2020 Oct 08, 2020	BUY	$33.21 - $51.27 $1,328 - $2,050	40 Added 0.32%	12,610 $543,000
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $12,015 - $19,904	460 Added 3.8%	12,570 $543,000
Q1 2020 Apr 28, 2020	SELL	$20.56 - $63.12 $1,850 - $5,680	-90 Reduced 0.74%	12,110 $348,000
Q4 2019 Feb 06, 2020	SELL	$28.14 - $73.01 $68,380 - $177,414	-2,430 Reduced 16.61%	12,200 $774,000
Q3 2019 Oct 09, 2019	BUY	$26.26 - $34.86 $787 - $1,045	30 Added 0.21%	14,630 $412,000
Q2 2019 Jul 09, 2019	BUY	$17.43 - $28.82 $254,478 - $420,772	14,600 New	14,600 $387,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account